Consensus of infectious complications in patients treated with selected biological therapies.Screening of hepatitis B in high risk Chilean and immigrant pregnant women: Management of mother to child transmission Second part: Chilean Guidelines for Prevention of Infections associated to use of Biological Therapies (PREVITEB)

• Published in: Revista chilena de infectología Vol. 36; no. 5; pp. 616 - 628
• Main Authors: Cerón, Inés, Vizcaya, Cecilia, Gambra, Pilar, Ferres, Marcela, Bidart, Teresa, López, Tania, Acuña, María Paz, Álvarez, Ana María, Zubieta, Marcela, Rabello, Marcela, Durán, Luisa, Rabagliati, Ricardo
• Format: Journal Article
• Language: Spanish
• Published: Chile 01.10.2019
• Subjects: Biological Therapy - adverse effects; Chile; Communicable Diseases - chemically induced; Consensus; Emigrants and Immigrants; Female; Hepatitis B - chemically induced; Hepatitis B - prevention & control; Humans; Infectious Disease Transmission, Vertical - prevention & control; Mass Screening; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious - chemically induced; Pregnancy Complications, Infectious - prevention & control; Risk Assessment; Risk Factors; Chile
• ISSN: 0717-6341
• DOI: 10.4067/S0716-10182019000500616

The use of biological therapies has meant a great improvement in the management of several conditions like autoimmune, neoplastic or others diseases. Although its use has implied significant improvements in the prognosis of these diseases, it is not exempt from complications: infectious diseases as one of them. The objective of this consensus was to evaluate, from an infectious viewpoint, the safeness of the most frequently used biological therapies and give recommendations for the prevention of infections in patients treated with these drugs. These recommendations were based on the highest quality evidence available for the selected biologics. The consensus counts of 2 manuscripts. This second part is a guideline that details these recommendations through screening strategies, prophylactic therapies and vaccines indications for bacterial, mycobacterial, viral, fungal and parasitic infections, both for adults and children.